Faculty

Bio

I received my BA from Luther College and my Masters of Biomedical Science at Lincoln Memorial  University.  I then earned my Medical Degree and Masters of Business Administration at DeBusk College of Osteopathic Medicine.  I completed my residency training in psychiatry here at the University of Minnesota where I served as Chief Resident. 

Within the department, my roles include Assistant Professor, Associate Program Director of the psychiatry residency program, and inpatient adult psychiatrist.  Clinically, I have a focus on acute psychosis and mood disorders with a special interest in PTSD and providing trauma-informed care. Medical education is a key focus of my career and my specific interests include teaching, leadership, and curriculum development research.  I teach psychiatry residents and medical students on the inpatient units and in the classroom with the goal of providing quality, evidence-based patient care while fostering a supportive learning environment for trainees.  

Within the University I also serve as Site Director for the medical student psychiatry rotation.

Expertise

• PTSD
• Psychosis
• Mood disorders

Administrative Assistant

(for academic support only)
Natasha Hampton-Anderson
nhampton@umn.edu

In the Media

• 2022: Featured in this article titled, “Making the transition from Chief Resident to Assistant Professor enables new faculty member to fuel her passion for medical education.”

Bio

I am a psychiatrist and biomedical engineer. Clinically, I provide brain stimulation treatments for mood, anxiety, and substance disorders. These include deep brain stimulation, cortical stimulation, and transcranial magnetic stimulation. 

My research focuses on developing these treatments further, particularly the creation of new "closed loop" devices. These devices sense brain signals in real-time and deliver energy in a planned and rational fashion, compensating for each patient's specific brain network abnormalities. My laboratory (TNE Lab) prototypes new stimulation paradigms and targets in rodent models, conducts clinical trials of these new technologies, and searches for biomarkers of illness and recovery to guide next-generation therapies. 

To inquire about being part of our neurostimulation trials or about existing clinical treatments, please contact my clinical office at 952-525-4500.

Expertise

• Neuromodulation for mental illness
• OCD

Administrative Assistant

(for academic support only)
Natasha Hampton-Anderson
nhampton@umn.edu

In the Media

• 2023: Featured in this WCCO TV piece titled, “New research at U of M measures brain waves to detect depression, suicide warnings.”
• 2023: Featured in this StarTribune article titled, “University of Minnesota studies brain's electrical signals as warnings for depression, suicide,” and in this WCCO interview titled, “ Can brain signals indicate thoughts about suicide and severe depression?”
• 2023: Dr. Widge and his research team are featured in this article titled, “Can we do a better job of detecting suicidality? U of M team using a DARPA award to test the possibility.”
• 2022: Featured in a video titled "Tackling Psychiatric Illness Using Translational Models and Computations", shot as part of the American Psychiatric Association's Conference TV with funding from NeuroPRSMH (NeuroPlasticity Research in Support of Mental Health), the U’s multidisciplinary neuroscience research group 
• 2022: Featured in this Psychiatric Times article titled, “Assessing Gaps and Opportunities in ECT, rTMS, and DBS Guidelines”.
• 2021: Spotlighted in The Medical Progress in a piece titled, “Merging AI with targeted electrical brain stimulation to improve specific human brain functions”.
• 2021: Interviewed for this MINNPOST piece titled, “As Minnesota considers qualifying anxiety for its medical cannabis program, psychiatrists raise concerns.
• U of M research team hopes to develop an implantable device to treat mental illness — thanks to a $6.6 million grant”. Features exciting work led by Dr. Alik Widge

Research Summary

Our laboratory develops new ways of modifying brain circuits to treat mental illness. We take a "dimensional" approach, breaking mental disorders into their core components that cut across diagnoses. We use a variety of tools, including electrical, magnetic, and optical stimulation, to change those circuits in a way we hope will translate to humans.

Bio

I received my BA from Cornell College, Iowa, and received my medical degree from Saint Louis University School of Medicine, Saint Louis, Missouri. I completed my residency in psychiatry at the University of California San Francisco – Fresno, California. I further completed my neuromodulation medicine fellowship here at the University of Minnesota, where I was its inaugural fellow. I am an adult psychiatrist with a focus on TMS. My unique interest in TMS is understanding TMS's mechanism in order to design optimal protocols and understand biomarkers for TMS clinical response to help make the best care decisions for patients.

Neuromodulation has been of interest to me since my work at a perinatal mental health clinic in California where I took care of women who were pregnant or had recently given birth who were always interested in the latest non-medication treatments. This really inspired me to become skilled to work with PTS who don't fully respond to medications. I provide and monitor neuromodulation techniques such as ECT, TMS, and VNS. Within the department, I am a member of the Diversity & Inclusion Committee.

Expertise

• ECT
• TMS
• VNS

Administrative Assistant

(for academic support only)
Shelly Slominski
slomi001@umn.edu

In the Media

• 2020: Interviewed by Minnesota Public Radio about seasonal affective disorder.

Bio

I am the Chief Clinical Psychologist for the Department of Psychiatry & Behavioral Sciences, and an Assistant Program Director in our psychiatry residency program. I am also a member of the Inclusive Excellence and Well-Being (IEWB) council. I earned my PhD in clinical psychology at Long Island University in Brooklyn, NY, and my BA at Brandeis University in Waltham, MA. I completed my predoctoral internship at NYU-Bellevue Hospital Center. Prior to joining the University of Minnesota Medical School, I was an Assistant Professor and Attending Psychologist at Albert Einstein College of Medicine/Montefiore Medical Center in the Bronx, NY. 

I provide individual psychotherapy to adults at our Riverside location, and supervise trainees and clinicians in psychiatry, psychology, and social work. My clinical interests and experience are largely in cognitive behavioral and psychodynamic therapy. I am a co-investigator for research studies funded by the EPINET (Early Psychosis Intervention Network) project, an NIMH grant through Dr. Vinogradov's lab, and I provide program support and clinical consultation to our Strengths and NAVIGATE specialty teams for patients experiencing psychosis.

Expertise

• Psychotherapy
• Voice-hearing
• Existential angst
• Psychosis 

Administrative Assistant

(for academic support only)
Molly Jokimaki
jokim004@umn.edu

Bio

I received my Ph.D. in Clinical Psychology at Kent State University in 1997, completed an internship at the University of Minnesota in 1997, and a post-doctoral fellowship in Pediatric Neuropsychology at the University of Minnesota in 1999. I am a Professor in the Department of Psychiatry & Behavioral Sciences and the Director of Child and Adolescent Mental Health Research.  I am also an adjunct faculty member in the Department of Psychology.

For more than 20 years, I have run a Child and Adolescent Neuropsychology Clinic in the Department of Psychiatry & Behavioral Sciences where I see patients with a variety of neurodevelopmental, neurological, and psychiatric conditions. I also train graduate students and clinical psychology interns in the practice of child and adolescent neuropsychology. My clinical interests include neuropsychological evaluation of children with neurological and psychiatric disorders, consultation with schools regarding academic programming and modifications, and clinical training.

My primary research interest is in Fetal Alcohol Spectrum Disorders (FASD). I direct the University's FASD Research Program. I conduct advanced neuroimaging studies in FASD in conjunction with the University's Laboratory for Neuropsychiatric Imaging. My research group is part of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) and is involved in CIFASD's ongoing multi-site imaging, neurobehavioral, genetic, facial dysmorphology, and intervention projects. In addition, I conduct randomized controlled trials of nutritional supplementation in children with FASD - the goal of which is to develop a treatment for the neurodevelopmental aspects of the disorder.  I am also conducting a trial of cognitive training and transcranial direct current stimulation in children and adolescents with FASD.

I also have a general interest in psychometrics and have been involved in the development of several neuropsychological instruments, including infant development and visual-perceptual processing measures. I am a member of the International Neuropsychological Society, Research Society on Alcoholism, and the past President of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG). I serve as a reviewer for a number of journals including JINS: the Journal of the International Neuropsychological Society, Child Neuropsychology, Pediatric Psychology, ACER: Alcoholism, Clinical and Experimental Research, Neurotoxicology and Teratology, and Development and Psychopathology, among others. I am also a longstanding member of our Clinical Psychology internship's Training Committee.

Expertise

• Neuropsychology (especially child and adolescent)
• Cognitive measurement
• MRI
• Clinical trials
• Study design
• Data analysis

Administrative Assistant

(for academic support only)
Molly Jokimaki
jokim004@umn.edu

In the Media

• 2023: Dr. Wozniak and his lab are spotlighted in this article titled, “Research team working on fetal alcohol syndrome disorders treatment, prevention.
• 2022: Featured in this piece titled, “Faculty member finds that working in an area that helps kids with FASDs is ‘pretty powerful’”.
• 2020: Dr. Wozniak’s research on Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders (FASD) was featured in an article titled, “'U' Announces Breakthrough Study On Treating Fetal Alcohol Spectrum Disorders”.

Bio

I received my BA in Psychology from Emory University. I completed my PhD in clinical psychology at the Illinois Institute of Technology. I did my internship here at the University of Minnesota Medical School and my postdoctoral fellowship in the child and adolescent mood program at Emory University School of Medicine. I am pursuing a Master’s in Public Health with an emphasis on Administration and Policy. 

I am a clinical child psychologist with expertise in interprofessional education and the care of families affected by trauma. I direct the Behavioral Health Clinic for Families which is an outpatient program dedicated to training psychology practicum students. I am also the Associate Training Director for our APA-Accredited Psychology Internship. 

Outside of the department, I serve as a faculty member for the Center for Interprofessional Health. My focus is on faculty and preceptor development so that educators are as well-versed in the principles of interprofessional education as our learners are. I co-founded the Workplace Interprofessional Learning and Development (WILD) Series as well as the CIH Affiliate Faculty Program. I also co-direct the Rothenberger Leadership Academy - a cohort-based leadership development program for physicians at the University of Minnesota Medical School.

Expertise

• Trauma-informed care of youths and families
• Interprofessional collaboration and education

Administrative Assistant

(for academic support only)
Molly Jokimaki
jokim004@umn.edu

In the Media

• 2023: Featured in this article titled, “Celebrating the many ways that psychologists help us.”
• 2022: Featured in this Office of Academic Clinical Affairs article titled, “New Interprofessional Program Helps Preceptors Advance Skills and Knowledge to Apply in the Clinical Learning Environment”.
• 2022: Featured in this article titled, “Psychology Week: one psychologist’s perspective about the profession”.
• 2021: Featured in this M Physicians article titled, “Behavioral Health Clinic for Families Reflects on a Successful Transition to Virtual Care”.
• 2021: Interviewed for this piece titled, “Life at the new Masonic Institute for the Developing Brain brings integration in care and learning, and opens opportunities for collaboration”.

Research Summary

Dr. Zagoloff's research focuses on interprofessional collaboration and education. This includes directing the department's move toward team based care and disseminating outcomes relating to this experience.  Additionally she tracks efforts at enhancing interprofessional learning opportunities among numerous groups of learners.

Clinical Summary

Dr. Zagoloff is a Licensed Psychologist in Minnesota and provides clinical services in the Child and Adolescent Anxiety program. She conducts psychological assessments as well as individual therapy for children, adolescents, and adults. In conjunction with individual therapy, Dr. Zagoloff conducts family therapy and parent guidance sessions when indicated. She is nationally certified in Trauma-Focused CBT.

Dr. Zagoloff has been trained in Cognitive-Behavioral, Dialectical Behavior, and Acceptance and Commitment Therapies as well as Behavioral Activation for depression.

Bio

Svetlana Zaydman, DO, has a true passion for improving lives with pain management and wellness therapies. She takes a comprehensive approach to pain management, utilizing therapies, medication, exercise, nutrition, and other lifestyle changes to relieve both acute and chronic pain. Each patient receives individualized care to develop a unique treatment plan to achieve positive, lasting results. With a keen understanding of the human body’s anatomy and function, she is dedicated to relieving patients’ pain and discomfort, so they gain renewed hope and improved quality of life. Dr. Zaydman believes in the powerful effect that people’s daily wellness choices have on their overall quality of life.

Before joining Valley Medical and Wellness, Dr. Zaydman was on the medical staff at The Atkins Center for Complementary Medicine in New York City, New York, where she worked under Dr. Robert Atkins, developer of the low-carbohydrate diet. She is triple-board-certified in physical medicine and rehabilitation, pain medicine, and addiction medicine. 

Dr. Zaydman co-founded Valley Medical and Wellness in 2014 and currently serves as the company's President and Medical Director. She is also an Adjunct Associate Professor at the University of Minnesota Medical School, Department of Psychiatry and Behavioral Sciences. She specializes in pain management, rehabilitation, and interventional headache pain management. As part of her comprehensive therapy protocols, she provides education and guidance on diet, exercise, and alternative wellness treatments to help patients feel their very best.

Bio

I am a psychologist and neuroimaging expert, a faculty member in the Department of Psychiatry and Behavioral Science, and a member of the Medical Discovery Team on Addiction. I received my PhD from Maastricht University in the Netherlands, where I developed fMRI-based neurofeedback training protocols for three different clinical populations. During my postdoctoral training at Mount Sinai, New York, I focused on the potential for personalized medical treatments in human drug addiction, investigating novel approaches for individualized treatments in cocaine-addicted individuals.

My current work focuses on establishing the existence of neurobiological subtypes in different addicted human populations, with the goal of developing individualized brain-based and technology-supported treatments for human drug addiction. My research group combines the analysis of existing large-scale multimodal data sets with the acquisition of new data through a variety of techniques such as interviewing, neurocognitive testing, questionnaires, and multi-modal neuroimaging. Novel computational methods are employed for linking social, demographic, neurocognitive, personality, and clinical measures to the neuroimaging data, to explore the existence of neurobiological subtypes within the addicted population. The goal of this research is to develop a neuroscience-derived individualized treatment for individuals who are at risk for either escalation of drug use or relapse. Within the department, I am a member of the Grand Rounds Committee.

Expertise

• Large-scale multimodal data sets
• MRI
• Human drug addiction treatment

Administrative Assistant

(for academic support only)
Shelly Slominski
slomi001@umn.edu

In the Media

• 2023: Dr. Zilverstand and her research team are featured in this article titled, “NIH grant enabling U of M team to identify factors involved in alcohol use disorder relapse following treatment.”
• 2023: Quoted in this Mpls Star Tribune article titled, “As Minnesota considers legalizing marijuana, what does research say about the risks?
• 2021: Dr. Zilverstand’s work with a national study is highlighted in this KSTP story titled, “U of M team leading 'largest study of early childhood brain development”. Her testimony before the Minnesota legislature earlier this year helped make the state’s portion of the study possible.
• 2021: Helped change a law to get some important research started in this article titled, “Lobbying Efforts Lead to Research Opportunities on the Effects of Substance Use on Families”.

Research Summary

Dr. Zilverstand's current work focuses on investigating how individual differences contribute to human drug addiction. Her research group combines the analysis of existing large-scale multimodal data sets with the acquisition of new data through a variety of techniques such as interviewing, neurocognitive testing, questionnaires and multi-modal neuroimaging. Novel computational methods are employed for linking social, demographic, neurocognitive, personality and clinical measures to the neuroimaging data, to explore the existence of neurobiological subtypes within the addicted population. The goal of this research is to develop neuroscience-derived individualized treatment for individuals who are at risk for either escalation of drug use or relapse.

Teaching Summary

Dr. Zilverstand is a faculty member of the Graduate Program in Neuroscience and provides training and supervision for neuroscience, psychology and psychiatry students, residents, and fellows in the University of Minnesota Medical School.

Clinical Summary

Dr. Zilverstand's clinical interests include addiction and other Impulse Control Disorders.

Bio

I am an Associate Professor for the Department of Psychiatry & Behavioral Sciences and a faculty member at the Bakken Center for Spirituality and Healing. I received my M.D. from the Wayne State University School of Medicine and obtained my psychiatry residency training at the University of California Los Angeles (UCLA). As part of my training I served as a Chief Resident of the UCLA Behavioral Health Clinic, completed the UCLA Robert Wood Johnson Clinical Scholars Program, and pursued additional training in mindfulness and integrative medicine. I am a graduate of the UCLA Center for East-West Medicine Fellowship and a  Diplomate of the American Board of Integrative Holistic Medicine. I have a particular focus on adult ADHD and mindfulness-based interventions. 

Through my research work as the UCLA Robert Wood Johnson Clinical Scholar, I pioneered the application of mindfulness in ADHD and co-developed the Mindful Awareness Practices (MAPs) for the ADHD program. I am a founding member of the UCLA Mindful Awareness Research and an author of an award-winning book The Mindfulness Prescription for Adult ADHD: An 8-Step Program for Strengthening Attention, Managing Emotions, and Achieving Your Goals, and a second book Mindfulness for Adult ADHD: A Clinician’s Guide.  

At the University of Minnesota, I serve as one of the key faculty of the UMN Adult Psychiatry Residency Program where I am an outpatient clinic supervisor for psychiatrists-in-training. I direct the Adult ADHD Clinic and lead the Integrative Psychiatry and Wellness Program. I am also a member of the Wellbeing and Impact Committee, Climate Committee, and Grand Rounds Committee.

Expertise

• ADHD

Administrative Assistant

(for academic support only)
Teneshia Collins
coll1148@umn.edu

In the Media

• 2023: Featured in this Wondermind article titled, “What Is Inattentive ADHD, and Do I Have It?”
• 2023: Featured in this issue of Childart dedicated to mindfulness. Her article titled, “Take Small Steps, Notice Your Emotions,” is on pages 26-27
• 2023: Featured in this Time online article titled, “What's Driving the Demand for ADHD Drugs Like Adderall.”
• 2023: Quoted in the Wondermind article titled, “Hold up, ADHD is a disability?”
• 2023: Quoted in this MedScape article titled, “ADHD Exacts Higher Mental Health Toll vs Autism in Adults.” 
• 2022: Quoted in this Huffington Post piece titled, “What It’s Really Like To Parent When You Have ADHD.”
• 2022: Featured in this online article titled, “Women with ADHD & ASD are Starting to Get Accurately Diagnosed — But it's Decades Late.”
• 2022: Featured in this piece titled, “Talking adult ADHD with U of M,” and this MPR piece, “No longer just a kid thing: more women diagnosed with ADHD later in life.
• 2022: Featured in this article titled, “Calm space: How to meditate when your brain wavers and you can't sit still”.
• 2022: Quoted in a Harper’s Bazaar article titled, “Coming Into Focus,” about a woman growing up with ADHD